Missing Data in Biologic Oncology Products

Author： Rothmann Mark   Koti Kallappa   Lee Kyung Yul   Lu Hong Laura   Shen Yuan Li  

Publisher： Taylor & Francis Ltd

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.19, Iss.6, 2009-11, pp. : 1074-1084

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Missing Data and Censoring in the Analysis of Progression-Free Survival in Oncology Clinical Trials

By Denne J. S.   Stone A. M.   Bailey-Iacona R.   Chen T.-T.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 951-970

Taylor & Francis Ltd

Access to resources Recommend Favorite

Editorial: Missing Data—Prevention and Analysis

By Soon Guoxing  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 941-944

Taylor & Francis Ltd

Access to resources Recommend Favorite

Missing Data in the Regulation of Medical Devices

By Campbell Gregory   Pennello Gene   Yue Lilly  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 2, 2011-03 ,pp. : 180-195

Taylor & Francis Ltd

Access to resources Recommend Favorite

Missing Data in Confirmatory Clinical Trials

By Flyer Paul   Hirman Joseph  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 969-979

Taylor & Francis Ltd

Access to resources Recommend Favorite

Addressing and Advancing the Problem of Missing Data

By Walton Marc  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 945-956

Taylor & Francis Ltd

Access to resources Recommend Favorite